News

The FDA has approved Bausch + Lomb’s Trulign lens, a toric posterior chamber IOL that corrects for astigmatism and has the capacity to deliver improved vision across a natural range of focus.

Senators from the Health, Education, Labor and Pensions (HELP) Committee have introduced a revised version of its draft compounding bill to help improve the safety of compounded human and animal drugs.

New Jersey has enacted legislation that requires insurance companies and health plans to provide coverage for the early refill of prescription eye drops at 70% of the predicted days of use.

Update on uveitis

Some older and newer treatments being studied for treating uveitis include iontophoresis, contact lenses, and nanoparticles.

Stephen J. Ryan, MD, a member of the Allergan Board of Directors, died on April 29, 2013 after a short illness.

A new PDUFA goal date has been established with the FDA for Iluvien fluocinolone acetonide implant (Alimera Sciences Inc.), and a PAS has been submitted to NICE in the United Kingdom.

New data show that a retinal prosthesis system is capable of providing face detection functionality to blind individuals, said Paulo E. Stanga, MD.